Since December 2001 we have been conducting a project to isolate and determine entire sequences of mouse KIAA cDNA clones which encode polypeptides corresponding to human KIAA proteins. The ultimate goal of this project is the elucidation of the functions of KIAA proteins. A critical step in this project is the generation of antibodies based on the cDNA sequence information. Although antibodies are the most optimal tools for biological analysis, the production and isolation of multiple recombinant proteins for an antigen is a rate-limiting step in antibody production. To address this problem, we established a system utilizing the in vitro recombination-assisted method and shotgun clones that were generated during the sequencing of mouse KIAA cDNAs (DNA Res. 2003, 10, 129-136). The authenticity of the expressed proteins was confirmed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Another critical step for antibody production is the evaluation of the antibodies. Thus, we also made efforts to develop a systematic approach for evaluation of the titer and the specificity of the antibodies. Using these systems, we have produced and evaluated more than 500 antibodies raised against mouse KIAA proteins to date. We are currently generating antibody arrays for analysis of protein expression profiles. We will verify protein-protein interactions using immunoprecipitation and tandem mass spectrometry analysis.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.200300704DOI Listing

Publication Analysis

Top Keywords

kiaa proteins
16
mouse kiaa
12
functions kiaa
8
critical step
8
step antibody
8
antibody production
8
mass spectrometry
8
kiaa
6
proteins
6
antibodies
6

Similar Publications

Identification of specific alterations in tumors (as a rule, these are mutations or gene fusions) makes it possible to prescribe targeted drugs of the second line of therapy or, in some cases of inoperable tumors, to observe not only a gradual partial response of the tumor to treatment, but also the removal of these patients from the category of incurable ones. The article describes a new rare type of gene fusion detected in a piloid astrocytoma that developed in the posterior cranial fossa in an 11-year-old boy.

View Article and Find Full Text PDF

Background And Purpose: and type 1 neurofibromatosis status are distinctive features in pediatric low-grade gliomas with prognostic and therapeutic implications. We hypothesized that DWI metrics obtained through volumetric ADC histogram analyses of pediatric low-grade gliomas at baseline would enable early detection of and type 1 neurofibromatosis status.

Materials And Methods: We retrospectively evaluated 40 pediatric patients with histologically proved pilocytic astrocytoma ( = 33), ganglioglioma ( = 4), pleomorphic xanthoastrocytoma ( = 2), and diffuse astrocytoma grade 2 ( = 1).

View Article and Find Full Text PDF
Article Synopsis
  • * Ipriflavone was identified as a potential drug, restoring staining of cartilage cells and increasing extracellular matrix formation in a dose-dependent manner.
  • * In both cell experiments and mouse models of arthritis, Ipriflavone improved symptoms and decreased hyaluronan levels, suggesting it may be an effective treatment for inflammatory arthritis.
View Article and Find Full Text PDF

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors.

J Cancer Res Clin Oncol

April 2022

Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tuebingen, Eberhard Karls University of Tuebingen, Calwerstr. 3, 72076, Tuebingen, Germany.

Purpose: Low-grade gliomas (LGG) and mixed neuronal-glial tumors (MNGT) show frequent MAPK pathway alterations. Oncogenic fibroblast growth factor receptor 1 (FGFR1) tyrosinase kinase domain has been reported in brain tumors of various histologies. We sought to determine the frequency of FGFR1 hotspot mutations N546 and K656 in driver-unknown LGG/MNGT and examined FGFR1 immunohistochemistry as a potential tool to detect those alterations.

View Article and Find Full Text PDF

Deleted in Breast Cancer 1 (DBC1) is an important metabolic sensor. Previous studies have implicated DBC1 in various cellular functions, notably cell proliferation, apoptosis, histone modification, and adipogenesis. However, current reports about the role of DBC1 in tumorigenesis are controversial and designate DBC1 alternatively as a tumor suppressor or a tumor promoter.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!